Contextualizing COVID-19 Consequences for Cancer Care is organized by Physicians' Education Resource LLC (PER).
Release Date: February 2, 2021
Expiration Date: February 2, 2022
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly escalated to a pandemic with significant morbidity and mortality resulting from the associated coronavirus disease 2019 (COVID-19).1 Approximately one-third of patients developing COVID-19 experienced severe complications, including acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia.2 Populations particularly vulnerable to COVID-19 include older adults and immunosuppressed patients. Patients with cancer are often immunosuppressed, whether caused by the malignancy or the treatment regimen they receive. As such, patients with cancer have an increased risk of infection with SARS-CoV-2 and greater COVID-19–related morbidity and mortality compared with the general population.3 In 2020, with COVID-19 remaining at the center of focus for healthcare professionals across disciplines, dynamic treatment strategies adapting to the demands of the pandemic have continued to be refined and implemented.
In this activity, Karen M. Winkfield, MD, PhD, discusses the challenges that the COVID-19 pandemic has presented in the clinical care of patients with cancer and epidemiological trends emerging for patients with cancer.
Upon successful completion of this activity, you should be better prepared to:
• Describe the major challenges in the clinical management of patients with cancer brought upon by the COVID-19 pandemic
• Outline clinical practice recommendations proposed by oncology societies regarding cancer care during the COVID-19 pandemic
• Assess individualized cancer screening and treatment modifications in the context of changing epidemiological characteristics of COVID-19
Additional details will be posted as soon as information is available.
Toll free Number
Healthcare Management +12 More
AMA PRA Category 1 Credit™ 10
Nursing +1 More
Oncology +1 More
Contact Hours 9